Mitchell Cairo, MD, is the Chief of Division of Pediatric Hematology, Oncology and Stem Cell Transplantation and Director of the Children’s and Adolescent Cancer and Blood Diseases Center at the New York Medical College, Valhalla, NY. Dr Cairo obtained his medical degree from the University of California, San Francisco, CA, and then he completed a residency in pediatrics at the University of California, Los Angeles, CA.
Dr Cairo is a former Board of Directors member of the International Society of Experimental Hematology, the Society for Hematology and Stem Cell Biology, and Chair of the Immuno and Gene Therapy Committee of the International Society for Cellular Therapy.
Speaking on acute leukemia and lymphoma
Dr Cairo’s wide research interests are particularly focused on lymphoma and acute leukemia in pediatric patients. Dr Cairo has several recent publications, including a study investigating the use of carbapenum on the risk of acute graft-versus-host disease in pediatric acute leukemia patients. Other involvements include a Phase I study investigating monotherapy and combination therapy of a cytokine in hematologic malignancies.